Answers are grounded in this paper and cite their sources.
Coupling biomass gasification with in situ CO 2 capture significantly enhances the yield of hydrogen. For this process, CaO is the most likely CO 2 sorbent. However, the development of a sorbent that is resistant to physical deterioration and maintains reactivity through multiple cycles is a limiting step in the scale-up and commercial operation of a continuous process. To this end, we describe an experimental protocol for screening CO 2 sorbents and then use this to assess the performance of six targeted CaO-based sorbents: CaO derived from commercially available CaCO 3 ( d p = 25.8 µm), commercially available Ca(OH) 2 ( d p = 9.2 µm), precipitated CaCO 3 ( d p = 3.2 µm), CaCO 3 nanoparticles ( d p = 509.4 nm), and presintered CaO doped with Li 2 CO 3 and with K 2 CO 3 . The protocol allows the measurement of reactivity through multiple CO 2 capture-and-release cycles; this is a significant step in determining the overall consumption of sorbent and, hence, the cost of one of the key parts of the process.
No takes yet. Share an insight, caveat, or question.
Florin et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: